Research output per year
Research output per year
Personal profile
Biographical details
CRUK Programme Foundation Award
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Igor Vivanco is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
DUSP4 protects BRAF- and NRAS-mutant melanoma from oncogene overdose through modulation of MITF
Gutierrez-Prat, N., Zuberer, H. L., Mangano, L., Karimaddini, Z., Wolf, L., Tyanova, S., Wellinger, L. C., Marbach, D., Griesser, V., Pettazzoni, P., Bischoff, J. R., Rohle, D., Palladino, C. & Vivanco, I., Sept 2022, In: Life Science Alliance. 5, 9, e202101235.Research output: Contribution to journal › Article › peer-review
Open Access12 Citations (Scopus) -
Targeting un-MET needs in advanced non-small cell lung cancer
Coleman, N., Harbery, A., Heuss, S., Vivanco, I. & Popat, S., Feb 2022, In: Lung Cancer. 164, p. 56-68 13 p.Research output: Contribution to journal › Article › peer-review
17 Citations (Scopus) -
Clinical development of AKT inhibitors and associated predictive biomarkers to guide patient treatment in cancer medicine
Coleman, N., Moyers, J. T., Harbery, A., Vivanco, I. & Yap, T. A., 2021, In: Pharmacogenomics and Personalized Medicine. 14, p. 1517-1535 19 p.Research output: Contribution to journal › Review article › peer-review
Open Access40 Citations (Scopus)
-
Evaluating the therapeutic potential and molecular mechanism of apilimod-induced ectopic c-MET localisation in paediatric cancers
Vivanco, I. (Primary Investigator)
1/01/2025 → 31/12/2025
Project: Research
-
Interrogating the therapeutic impact of MYB overdose brought on by AKT inhibitor treatment in blood cancers
Vivanco, I. (Primary Investigator) & Parsons, R. (Co-Investigator)
1/09/2023 → 31/08/2027
Project: Research
-
Evaluating the therapeutic potential and molecular mechanism of drug-induced c-MET mislocalisation in small-cell lung cancer
Vivanco, I. (Primary Investigator) & Myint, K. N. (Co-Investigator)
1/01/2026 → 31/12/2026
Project: Research
-
Evaluating the potential of allosteric AKT inhibitors in cardiovascular disease
Vivanco, I. (Primary Investigator)
1/06/2024 → 31/12/2024
Project: Research
-
Benchmark MyTemp 65HC Digital Incubator for Drosophila
Parsons, R. (Primary Investigator) & Vivanco, I. (Co-Investigator)
1/03/2024 → 31/05/2024
Project: Research